Sanford S. Zweifach's most recent trade in Carisma Therapeutics Inc was a trade of 19,350 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 26, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Carisma Therapeutics Inc | Sanford S. Zweifach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 19,350 | 19,350 | - | - | Stock Option (Right to Buy) | |
Essa Pharma Inc | Sanford S. Zweifach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 50,000 | 50,000 | - | - | Options | |
Carisma Therapeutics Inc | Sanford S. Zweifach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 38,700 | 38,700 | - | - | Stock Option (Right to Buy) | |
Essa Pharma Inc | Sanford S. Zweifach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) |